In the News November 29, 2017

The Pink Sheet | Combination Therapies: Incentives Needed To Encourage Labeling Across Products

Marc Scheineson comments on the need for the U.S. Food and Drug Administration to streamline the process for ensuring that drugs used together as part of a treatment regimen are similarly labeled for combination therapy.
Media Contact
Nicholas Clarke
Senior Communications Manager
Phone: 212.210.1222

This website uses cookies to improve functionality and performance. For more information, see our Privacy Statement. Additional details for California consumers can be found here.